Abstract C031: A Randomized Phase 1b Study of IGM-8444 in Combination with FOLFIRI + Bevacizumab Compared to FOLFIRI + Bevacizumab Alone in Second Line Metastatic Colorectal CancerSusanna V. Ulahannan,Meredith S. Pelster,Patricia LoRusso,Gerald S. Falchook,Judy Wang, Minal Barve,Jaspreet Singh Grewal,Warren Chow,Jason T. Henry,Michael Cecchini,Vivek Subbiah,Maya Leabman,Genevive Hernandez, Lijia Yao,Angus M. Sinclair,Béatrice Wang,Maya F. Kotturi,Eric W. Humke, Sean Ahern, Leslie Ennis, Melaine Caruano, Sapeck AgrawalMolecular cancer therapeutics（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
